Rene A Amadore*, Ramar John Bangayan and Therese Eileen L Natividad

Department of Internal Medicine, East Avenue Medical Center, Philippines

*Corresponding Author: Rene A Amadore, Department of Internal Medicine, East Avenue Medical Center, Philippines.

Received: May 05, 2022; Published: June 03, 2022

Abstract

This is a case of a 59-year-old female who presented with a two-year history of heliotrope rash, Gottron's papules, shawl sign, V-neck sign, and muscle weakness. She was previously managed as a case of systemic lupus erythematosus, who initially responded to unrecalled corticosteroids. She was, however, admitted due to a one-month of progressively enlarging sacral mass which eventually turned out to be an abscess. While the abscess was being treated, her autoimmune condition was worked up and she was then managed as a case of Clinically Amyopathic Dermatomyositis (CADM) with Interstitial Lung Disease (ILD). She received corticosteroids and underwent the first cycle of cyclophosphamide infusion prior to discharge.

Keywords: Clinically Amyopathic Dermatomyositis; Interstitial Lung Disease

Bibliography

1. Plotz PH., et al. “Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy”. Annals of Internal Medicine 122 (1995): 715-724.
2. Linos E., et al. “Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey”. Arthritis Research and Therapy 1 (2013): R7.
3. Jakubaszek M., et al. “Polymyositis and dermatomyositis as a risk of developing cancer”. Reumatologia 53 (2015): 101-105.
4. Abhinav K Misra., et al. “Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies”. BMC Pulmonary medicine 21 (2021): 370.
5. Leclair V and Lundberg IE. “New myositis classification criteria what we have learned since Bohan and Peter”. Current Rheumatology Report 20 (2018): 18.
6. Umaima Marvi., et al. “Clinical Presentation and Evaluation of Dermatomyositis”. Indian Journal of Dermatology 5 (2012): 375-381.
7. Wilsher ML., et al. “Hypercalcaemia during resolution of calcinosis in juvenile dermatomyositis”. British Medical Journal (Clin Res Ed) 288 (1984): 1345.
8. Gerardo Gutiérrez Gutiérrez., et al. “Use of Electromyography in the Diagnosis of Inflammatory Myopathies”. Reumatologia Clinica4 (2011): 195-200.
9. A Bohan., et al. “Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis”. Medicine (Baltimore) 56 (1977): 255.
10. R Levin., et al. “Phillips 2^nd. The time course of creatine kinase elevation following concentric needle EMG”. Muscle Nerve 10 (1987): 242-245.
11. Smith RL., et al. “Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops”. Journal of Rheumatology 31 (2004): 1644-1649.
12. Fathi M., et al. “Pulmonary complications of polymyositis and dermatomyositis”. Seminars in Respiratory and Critical Care Medicine 28 (2007): 451-458.
13. Sato S and Kuwana M. “Clinically amyopathic dermatomyositis”. Current Opinion on Rheumatology 22 (2010): 639-643.
14. Fathi M and Lundberg IE. “Interstitial lung disease in polymyositis and dermatomyositis”. Current Opinion on Rheumatology 17 (2005): 701-706.
15. Brent W Smith., et al. “Suspect myopathy? Take this approach to the work-up”. The Journal of Family Practice 11 (2014): 631-637.
16. V Cottin., et al. “Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis”. European Respiratory Journal 22 (2003): 245-250.
17. Tsuji H., et al. “Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by antimelanoma differentiation-associated gene 5-positive dermatomyositis”. Arthritis Rheumatology3 (2020): 488-498.
18. Kazuhiro Kurasawa Satoko Arai. “Optimal management of interstitial lung disease associated with dermatomyositis/polymyositis: lessons from the Japanese experience”. Dove Press4 (2014): 93-107.
19. John Okogbaa and Lakeasha Batiste. “Dermatomyositis: An Acute Flare and Current Treatments”. National Library of Medicine 12 (2019): 1179547619855370
20. Felix Paolo J Lizaronda and Eileen Liesl A Cubillan. “Clinically Amyopathic Dermatomyositis Associated with a Metastatic Undifferentiated Carcinoma in an Adult Filipino Male: A Case Report”. Acta Medica Philippina2 (2019): 198-201.
21. Gan Yu-Zhou., et al. “Risk factors of interstitial lung diseases in clinically amyopathic dermatomyositis” 1.6 (2020): 644-649.
22. Satoshi Ikeda., et al. “Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?” BMC Pulmonary Medicine 15 (2015): 159.
23. Pedram Gerami., et al. “A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): A missing link within the spectrum of the idiopathic inflammatory myopathies”. Journal of the American Academy of Dermatology4 (2006): 597-613.

Citation: Rene A Amadore., et al. “A Rare Case of Clinically Amyopathic Dermatomyositis in a Filipino Female". Acta Scientific Clinical Case Reports 3.7 (2022): 10-15.

Copyright: © 2022 Rene A Amadore., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.